Effects of intravenous cyclophosphamide in severe proliferative lupus glomerulonephritis.
Tovar
J L
JL
Division of Nephrology, Hospital General Valle de Hebrón, Barcelona, Spain.
Ordi
J
J
Martinez
S
S
Raventos
A
A
Ramirez de Arellano
M
M
Selva
A
A
Vidal
M T
MT
Piera
L
L
D000293:Adolescent; D000328:Adult; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D008181:Lupus Nephritis / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008297:Male
D003520:Cyclophosphamide; D003404:Creatinine